DAFNA Capital Management as of March 31, 2020
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 80 positions in its portfolio as reported in the March 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Stereotaxis (STXS) | 17.2 | $41M | 14M | 3.02 | |
Blueprint Medicines (BPMC) | 5.6 | $13M | 228k | 58.48 | |
Fate Therapeutics (FATE) | 4.4 | $10M | 470k | 22.21 | |
Galapagos Nv- (GLPG) | 3.8 | $9.1M | 46k | 195.92 | |
Dex (DXCM) | 3.7 | $9.0M | 33k | 269.27 | |
AtriCure (ATRC) | 3.4 | $8.1M | 240k | 33.59 | |
iShares NASDAQ Biotechnology Index (IBB) | 3.3 | $7.9M | 73k | 107.74 | |
Arena Pharmaceuticals | 3.1 | $7.5M | 180k | 42.00 | |
Neurocrine Biosciences (NBIX) | 2.9 | $6.9M | 80k | 86.55 | |
Proqr Thrapeutics N V shs euro (PRQR) | 2.8 | $6.8M | 1.2M | 5.49 | |
Akebia Therapeutics (AKBA) | 2.7 | $6.5M | 854k | 7.58 | |
Luminex Corporation | 2.3 | $5.6M | 204k | 27.53 | |
Cara Therapeutics (CARA) | 2.0 | $4.9M | 371k | 13.21 | |
Sage Therapeutics (SAGE) | 2.0 | $4.7M | 165k | 28.72 | |
Compugen (CGEN) | 1.8 | $4.4M | 600k | 7.26 | |
Aerie Pharmaceuticals | 1.7 | $4.0M | 293k | 13.50 | |
Xenon Pharmaceuticals (XENE) | 1.6 | $3.9M | 347k | 11.34 | |
Corbus Pharmaceuticals Hldgs | 1.6 | $3.9M | 747k | 5.24 | |
Applied Genetic Technol Corp C | 1.6 | $3.8M | 1.2M | 3.28 | |
Ascendis Pharma A S (ASND) | 1.6 | $3.8M | 34k | 112.61 | |
Alector (ALEC) | 1.6 | $3.7M | 155k | 24.13 | |
Zogenix | 1.5 | $3.5M | 143k | 24.73 | |
Mirati Therapeutics | 1.4 | $3.2M | 42k | 76.86 | |
Biohaven Pharmaceutical Holding | 1.3 | $3.1M | 91k | 34.03 | |
Kura Oncology (KURA) | 1.3 | $3.1M | 308k | 9.95 | |
Radius Health Inc note 3.000% 9/0 | 1.2 | $2.8M | 4.0M | 0.71 | |
Dicerna Pharmaceuticals | 1.1 | $2.7M | 148k | 18.37 | |
Axovant Gene The | 1.0 | $2.5M | 1.0M | 2.44 | |
Mersana Therapeutics (MRSN) | 1.0 | $2.3M | 402k | 5.83 | |
Kadmon Hldgs | 1.0 | $2.3M | 557k | 4.19 | |
Biotelemetry | 1.0 | $2.3M | 61k | 38.51 | |
Viking Therapeutics (VKTX) | 0.9 | $2.1M | 451k | 4.68 | |
Turning Point Therapeutics I | 0.9 | $2.1M | 47k | 44.66 | |
Cardiovascular Systems | 0.8 | $1.8M | 51k | 35.21 | |
Kalvista Pharmaceuticals (KALV) | 0.7 | $1.8M | 235k | 7.65 | |
Affimed Therapeutics B V | 0.7 | $1.8M | 1.1M | 1.58 | |
Harpoon Therapeutics | 0.7 | $1.7M | 148k | 11.58 | |
Epizyme | 0.7 | $1.6M | 106k | 15.51 | |
Apellis Pharmaceuticals (APLS) | 0.6 | $1.4M | 54k | 26.79 | |
Autolus Therapeutics Plc spon ads (AUTL) | 0.5 | $1.3M | 220k | 5.99 | |
Accuray Incorporated (ARAY) | 0.5 | $1.3M | 674k | 1.90 | |
Johnson & Johnson (JNJ) | 0.5 | $1.2M | 9.4k | 131.17 | |
Inogen (INGN) | 0.5 | $1.2M | 23k | 51.65 | |
Bluebird Bio (BLUE) | 0.5 | $1.2M | 26k | 45.96 | |
Zymeworks | 0.5 | $1.1M | 32k | 35.47 | |
Phasebio Pharmaceuticals | 0.4 | $1.1M | 321k | 3.31 | |
Ardelyx (ARDX) | 0.4 | $1.1M | 185k | 5.69 | |
Natus Medical | 0.4 | $992k | 43k | 23.12 | |
BioCryst Pharmaceuticals (BCRX) | 0.4 | $958k | 479k | 2.00 | |
Neuronetics (STIM) | 0.4 | $937k | 496k | 1.89 | |
Genocea Biosciences (GNCAQ) | 0.4 | $933k | 543k | 1.72 | |
Otonomy | 0.4 | $924k | 469k | 1.97 | |
Prevail Therapeutics Ord | 0.4 | $914k | 75k | 12.19 | |
Madrigal Pharmaceuticals (MDGL) | 0.4 | $908k | 14k | 66.76 | |
Macrogenics (MGNX) | 0.4 | $873k | 150k | 5.82 | |
Synlogic | 0.4 | $861k | 501k | 1.72 | |
Cytomx Therapeutics (CTMX) | 0.3 | $767k | 100k | 7.67 | |
Nextcure (NXTC) | 0.3 | $741k | 20k | 37.05 | |
Arcturus Therapeutics Hldg I (ARCT) | 0.3 | $715k | 53k | 13.60 | |
Dexcom Inc dbcv 0.750% 5/1 | 0.3 | $687k | 250k | 2.75 | |
Tcr2 Therapeutics Inc cs | 0.3 | $610k | 79k | 7.74 | |
Argenx Se (ARGX) | 0.2 | $589k | 4.5k | 131.74 | |
Morphic Hldg (MORF) | 0.2 | $543k | 37k | 14.68 | |
Masimo Corporation (MASI) | 0.2 | $531k | 3.0k | 177.00 | |
Assembly Biosciences | 0.2 | $528k | 36k | 14.84 | |
Gamida Cell | 0.2 | $449k | 149k | 3.02 | |
Karuna Therapeutics Ord | 0.2 | $449k | 6.2k | 72.06 | |
Sutro Biopharma (STRO) | 0.2 | $408k | 40k | 10.20 | |
Exicure | 0.2 | $407k | 275k | 1.48 | |
Spero Therapeutics (SPRO) | 0.2 | $389k | 48k | 8.09 | |
Arcus Biosciences Incorporated (RCUS) | 0.2 | $386k | 28k | 13.89 | |
Eloxx Pharmaceuticals | 0.2 | $375k | 192k | 1.96 | |
Gritstone Oncology Ord (GRTSQ) | 0.1 | $291k | 50k | 5.82 | |
Radius Health | 0.1 | $286k | 22k | 13.00 | |
Rigel Pharmaceuticals | 0.1 | $246k | 158k | 1.56 | |
Zafgen | 0.1 | $235k | 306k | 0.77 | |
Bioxcel Therapeutics (BTAI) | 0.0 | $103k | 4.6k | 22.32 | |
Aslan Pharmaceuticals Adr ads | 0.0 | $88k | 86k | 1.02 | |
Lineage Cell Therapeutics In (LCTX) | 0.0 | $79k | 95k | 0.83 | |
Urogen Pharma (URGN) | 0.0 | $42k | 2.4k | 17.73 |